InvestmentUpdated on 16 December 2025
Funding
CEO at Phagestack GmbH
Pulheim, Germany
About
As we scale our Data-as-a-Service (DaaS) platform and expand our laboratory capabilities, we are actively seeking funding to accelerate R&D and continue the development of a high-throughput phage isolation and characterization system to prototype level. We welcome conversations with investors interested in supporting groundbreaking advancements in precision antimicrobials.
Attached files
Similar opportunities
Product
Innovative Test Bench - Equipment development for precise emulsions and formulation
Tanguy Van Regemorter
CEO at Manetco SRL
Ohain, Belgium
Partnership
Open Collaboration & Strategic R&D Partnerships
Krishna Sampathkumar
Founder at JR Research and Development
Limburg Province, Netherlands
Project cooperation
Cooperation in combating antimicrobial resistance
Balázs Libisch
Senior Research Associate at Institute of Genetics and Biotechnology, Hungarian University of Agriculture and Life Sciences
Gödöllő, Hungary